Neurological toxicity after phenytoin infusion in a pediatric patient with epilepsy: Influence of CYP2C9, CYP2C19 and ABCB1 genetic polymorphisms

Article

Abstract: Pharmacogenetic studies have shown that genetic defects in drug-metabolizing enzymes encoded by CYP2

Palabras claves:

CYP2C19, CYP2C9, Epilepsy, Neurological toxicity, paediatric, Phenytoin

Autores:

Adrián LLerena, Dorado P., López-Torres E., Martínez-Antón J., Penãs-Lledó E.M.

Fuentes:

scopus